AIG07025
/ AIGEN Sci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Discovery and preclinical characterization of AIG07025, a potent and selective USP1 inhibitor with broad combination potential
(AACR 2026)
- "Abstract is embargoed at this time."
Late-breaking abstract • Preclinical • Oncology • USP1
1 to 1
Of
1
Go to page
1